SG11202011007UA - Methods for early prediction, treatment response, recurrence and prognosis monitoring of breast cancer - Google Patents
Methods for early prediction, treatment response, recurrence and prognosis monitoring of breast cancerInfo
- Publication number
- SG11202011007UA SG11202011007UA SG11202011007UA SG11202011007UA SG11202011007UA SG 11202011007U A SG11202011007U A SG 11202011007UA SG 11202011007U A SG11202011007U A SG 11202011007UA SG 11202011007U A SG11202011007U A SG 11202011007UA SG 11202011007U A SG11202011007U A SG 11202011007UA
- Authority
- SG
- Singapore
- Prior art keywords
- recurrence
- methods
- breast cancer
- treatment response
- early prediction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862668435P | 2018-05-08 | 2018-05-08 | |
| PCT/US2019/031292 WO2019217537A1 (en) | 2018-05-08 | 2019-05-08 | Methods for early prediction, treatment response, recurrence and prognosis monitoring of breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202011007UA true SG11202011007UA (en) | 2020-12-30 |
Family
ID=68468332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202011007UA SG11202011007UA (en) | 2018-05-08 | 2019-05-08 | Methods for early prediction, treatment response, recurrence and prognosis monitoring of breast cancer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210189500A1 (en) |
| EP (1) | EP3790984B1 (en) |
| JP (1) | JP2021522814A (en) |
| KR (1) | KR20210042263A (en) |
| CN (1) | CN112534069A (en) |
| AU (1) | AU2019265619A1 (en) |
| PL (1) | PL3790984T3 (en) |
| SG (1) | SG11202011007UA (en) |
| TW (1) | TWI721414B (en) |
| WO (1) | WO2019217537A1 (en) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140113286A1 (en) * | 2010-12-21 | 2014-04-24 | Sloan-Kettering Institute For Cancer Research | Epigenomic Markers of Cancer Metastasis |
| JP2014505475A (en) * | 2011-01-20 | 2014-03-06 | ユニヴェルシテ リブル ドゥ ブリュッセル | Epigenetic portrait of human breast cancer |
| EP3194624B1 (en) * | 2014-09-15 | 2022-02-16 | Garvan Institute of Medical Research | Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor |
| WO2017119510A1 (en) * | 2016-01-08 | 2017-07-13 | 国立大学法人京都大学 | Test method, gene marker, and test agent for diagnosing breast cancer |
| US10058293B2 (en) * | 2016-02-19 | 2018-08-28 | Morpho Detection, Llc | Detector assemblies and methods for helical CT scanning |
| EP3452620A4 (en) * | 2016-05-04 | 2020-01-01 | Queen's University At Kingston | Cell-free detection of methylated tumour dna |
| EP3717644A4 (en) * | 2017-11-30 | 2021-12-29 | Mayo Foundation for Medical Education and Research | Detecting breast cancer |
-
2019
- 2019-05-08 WO PCT/US2019/031292 patent/WO2019217537A1/en unknown
- 2019-05-08 US US17/053,688 patent/US20210189500A1/en active Pending
- 2019-05-08 PL PL19799344.7T patent/PL3790984T3/en unknown
- 2019-05-08 AU AU2019265619A patent/AU2019265619A1/en active Pending
- 2019-05-08 SG SG11202011007UA patent/SG11202011007UA/en unknown
- 2019-05-08 CN CN201980031343.5A patent/CN112534069A/en active Pending
- 2019-05-08 EP EP19799344.7A patent/EP3790984B1/en active Active
- 2019-05-08 TW TW108115948A patent/TWI721414B/en active
- 2019-05-08 KR KR1020207035311A patent/KR20210042263A/en active Search and Examination
- 2019-05-08 JP JP2020562713A patent/JP2021522814A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019265619A1 (en) | 2020-12-03 |
| PL3790984T3 (en) | 2024-04-02 |
| EP3790984C0 (en) | 2023-11-22 |
| EP3790984A4 (en) | 2022-03-09 |
| TWI721414B (en) | 2021-03-11 |
| KR20210042263A (en) | 2021-04-19 |
| JP2021522814A (en) | 2021-09-02 |
| CN112534069A (en) | 2021-03-19 |
| EP3790984B1 (en) | 2023-11-22 |
| TW202006142A (en) | 2020-02-01 |
| US20210189500A1 (en) | 2021-06-24 |
| EP3790984A1 (en) | 2021-03-17 |
| WO2019217537A1 (en) | 2019-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3524689C0 (en) | Method for predicting the prognosis of breast cancer patient | |
| SG11202004159WA (en) | Machine learning-based method for prediction of breast cancer prognosis using next-generation sequencing, and prediction system therefor | |
| EP3194624A4 (en) | Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor | |
| EP3622071A4 (en) | Circulating rna for detection, prediction, and monitoring of cancer | |
| SG11201907102XA (en) | Immunological biomarker for predicting clinical effect of cancer immunotherapy | |
| MX2017007707A (en) | Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer. | |
| EP3322823A4 (en) | Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor | |
| MX2017000840A (en) | Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer. | |
| IL288970A (en) | Methods of detecting and predicting breast cancer | |
| IL269552A (en) | Diagnostic methods and kits for early detection of ovarian cancer | |
| IL276089A (en) | Methods for colon cancer detection and treatment monitoring | |
| IL283780A (en) | Transcriptomic profiling for prognosis of breast cancer | |
| IL268235A (en) | Improved methods for assessing risk of developing breast cancer | |
| EP3880246A4 (en) | Method of improving prediction of response for cancer patients treated with immunotherapy | |
| MA40636A (en) | Methods of detecting prostate cancer | |
| IL273844A (en) | Methods of assessing risk of developing breast cancer | |
| SG11202106398WA (en) | Methods and genomic classifiers for prognosis of breast cancer and predicting benefit from adjuvant radiotherapy | |
| EP3292218A4 (en) | Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer | |
| EP3605087A4 (en) | Method for predicting therapeutic effect and/or recurrence monitoring in cancer patients | |
| EP3415914A4 (en) | Method, biomarker and diagnostic agent for detection of high-risk prostate cancer | |
| GB201619808D0 (en) | Biomarkers for the prognosis and diagnosis of cancer | |
| SG11202011007UA (en) | Methods for early prediction, treatment response, recurrence and prognosis monitoring of breast cancer | |
| EP3639028A4 (en) | Diagnostic, prognostic, and monitoring methods for solid tumor cancers | |
| IL268274A (en) | Methods of diagnosing malignant diseases | |
| GB201905861D0 (en) | Methods of detecting cancer |